Alexion Pharmaceuticals Inc.

Alexion Pharmaceuticals Inc.

ALXN

Market Cap$0
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Alexion Pharmaceuticals Inc.Alexion Pharmaceuticals Inc.66.3-5%6.50.2
$196.03

Current Fair Value

7.4% upside

Undervalued by 7.4% based on the discounted cash flow analysis.

Share Statistics

Market cap$0.00
Enterprise Value$-937,300,000.00
Dividend Yield$0 (0%)
Earnings per Share$2.75
Beta1.26
Outstanding Shares220,100,000

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio66.27
PEG471.31
Price to Sales6.52
Price to Book Ratio3.26
Enterprise Value to Revenue-0.15
Enterprise Value to EBIT-0.32
Enterprise Value to Net Income-2
Total Debt to Enterprise-2.7
Debt to Equity0.2

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Alexion Pharmaceuticals Inc.

CEO: Leonard Bell